Skip to content

Role of effect and Safety on Phaltrikadi Kwath Vati with and without Bilwadi Agada on Alcoholic Liver Steatosis

A comparative clinical study on phaltrikadi kwath vati with and without bilwadi agada on alcoholic liver steatosis with special reference to gara visha janya yakrut vikara

Status
Active, not recruiting
Phases
Phase 2Phase 3
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2023/09/057507
Enrollment
30
Registered
2023-09-12
Start date
Unknown
Completion date
Unknown
Last updated
2023-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K700- Alcoholic fatty liver

Interventions

None listed

Sponsors

national Institute of Ayurveda- Jaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Patients having classical symptoms of Alcoholic Liver Steatosis Patients with or without having elevated liver enzyme level Patient with USG Abdomen with liver steatosis

Exclusion criteria

Exclusion criteria: Patients with Liver Toxicicty having symptoms of septicemia Patients with Alcoholic hepatitis, Alcoholic Cirrohsis, Portal Hypertension and end stage Liver Disease Patients having liver toxicity other than Gara Visha Pregnant and lactating women

Design outcomes

Primary

MeasureTime frame
Clinical Improvement of sings & symptoms of Alcoholic Liver Steatosis & Gara Visha janya Yakrit Vikara LakshanaTimepoint: Base line and after 45 days a

Secondary

MeasureTime frame
Reduce level of Biochemical para meters of Liver toxicity on Alcoholic Liver Steatosis ALT, AST, Alkaline Phosphatase, Total Bilirubin levelTimepoint: at baseline & after 45days

Countries

India

Contacts

Public ContactRanamuka Kankanamalage Nishani Priyangika

National Institute of Ayurveda- Jaipur,

dramolkaduayu@gmail.com9834366502

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026